GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
#4120-100-EB Human Fen_1 Enzyme and Buffer
Product name : Human Fen_1 Enzyme and Buffer
Catalog number : 4120-100-EB
Quantity: 100 Units
Supplier name : Trevigen
Data sheet: Ask more or other datasheet now !
More Details about
Description: FEN-1 is a 50 kDa endonuclease/exonuclease that functions in mammalian replication and repair. The enzyme shows similarity to the yeast Rad2 and Rad13 genes. FEN-1 was identified as a necessary component of Okazaki fragment processing and functions on a number of branched DNA structures. It has been shown that FEN-1 specifically associates with PCNA and this binding stimulates FEN-1 up to 50 fold.
Source: Purified from E. coli containing a recombinant plasmid encoding the human FEN-1 protein.
Unit Definition: One Unit cleaves 10 pmole of a 32P-labeled oligonucleotide flap complex in one hour at 30°C.
Specificity: FEN-1 catalyzes the nucleotide excision of DNA branch structures formed during replication of the lagging strand of DNA. The branch structures are formed due to the frequent mismatches that occur at the 5'-end of Okazaki fragments. FEN-1 is also involved in the endonucleolytic cleavage of branch structures that are formed during DNA double strand break end-joining. FEN-1 cleaves DNA flap structures one nucleotide distal to the elbow in the single-stranded region or one nucleotide proximal to the elbow in the double-stranded region, creating two possible cleavage products (see figure overleaf).
FEN-1 also has a 5'-3' exonuclease activity specific for recessed 5' ends. This exonuclease activity may be involved in the removal of initiator RNA of mammalian Okazaki fragments.
Assay Conditions: The flap substrate is prepared by hybridizing 100 pmole Flap Oligonucleotide labeled with 32P, 200 pmole Bridge Oligonucleotide, and 200 pmole Adjacent Oligonucleotide in 20 mM Tris (pH 7.4),15 mM NaCl in a 100 μl volume at 99°C for 10 minutes and then cooling slowly to 4°C. 1X REC™ Reaction Buffer 12, 1X BSA Additive (0.1 mg/ml BSA, 5% glycerol), 8 μl of the above 32P flap substrate, and serial dilutions of enzyme in a reaction volume of 20 μl are incubated for 1 hour at 30°C. For analysis, 5 μl of 5X REC™Loading Buffer (Cat# 4018-250: 20 mM EDTA, 20% Ficoll, and 0.2% bromophenol blue) are added, and cleavage products are resolved by 20% denaturing polyacrylamide gel electrophoresis. The bands are cut out and radioactivity counted to quantify the cleavage products.
Storage Conditions: Store at -20°C in a manual defrost freezer.
Storage Buffer: 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 1 mM DTT, 0.1 mg/ml BSA, and 50% (v/v) glycerol.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP142: mRNA processing
WP1493: Carbon assimilation C4 pathway
WP2107: pathways in human cancer
WP2340: Thiamine (vitamin B1) biosynthesis and salvage
WP2341: vitamin B1 (thiamin) biosynthesis and salvage pathway
WP2344: vitamin B6 (pyridoxine, pyridoxal, pyridoxamine) biosynthesis and salvage pathway
WP2349: vitamin B3 (niacin), NAD and NADP biosynthesis pathway
WP626: Abscisic Acid Biosynthesis
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[ELANE ELA2] Neutrophil elastase (EC 18.104.22.168) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase)
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[RACK1 GNB2L1 HLC7 PIG21] Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 22.214.171.124) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[SCN5A] Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5)
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[CCNDBP1 DIP1 GCIP HHM] Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)
[F8 F8C] Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]
[AKAP13 BRX HT31 LBC] A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 126.96.36.199) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)
[UBE3A E6AP EPVE6AP HPVE6A] Ubiquitin-protein ligase E3A (EC 188.8.131.52) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)
[HBB] Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin]
[gag-pol] Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 184.108.40.206) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 220.127.116.11) (EC 18.104.22.168) (EC 22.214.171.124) (Exoribonuclease H) (EC 126.96.36.199) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
[SIRT1 SIR2L1] NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
[APP A4 AD1] Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Beta-amyloid precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[GOLGA2] Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95)
[ZAK MLTK HCCS4] Mitogen-activated protein kinase kinase kinase MLT (EC 188.8.131.52) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK)
[LRRK2 PARK8] Leucine-rich repeat serine/threonine-protein kinase 2 (EC 184.108.40.206) (Dardarin)
[TGFB1 TGFB] Transforming growth factor beta-1 (TGF-beta-1) [Cleaved into: Latency-associated peptide (LAP)]
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 220.127.116.11) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[EPHA3 ETK ETK1 HEK TYRO4] Ephrin type-A receptor 3 (EC 18.104.22.168) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)
[SRC SRC1] Proto-oncogene tyrosine-protein kinase Src (EC 22.214.171.124) (Proto-oncogene c-Src) (pp60c-src) (p60-Src)
[TRIP13 PCH2] Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein) (16E1-BP) (HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13)
[KCNQ1 KCNA8 KCNA9 KVLQT1] Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)
[SCN1A NAC1 SCN1] Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
[FGFR2 BEK KGFR KSAM] Fibroblast growth factor receptor 2 (FGFR-2) (EC 126.96.36.199) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
[DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4] DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)
[TTN] Titin (EC 188.8.131.52) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
 Genetic analyses of the fusion protein genes in human parainfluenza virus types 1 and 3 among patients with acute respiratory infections in Eastern Japan from 2011 to 2015.
 Embodying pervasive discrimination: a decomposition of sexual orientation inequalities in health in a population-based cross-sectional study in Northern Sweden.
 An assessment of the overexpression of BMP 2 in transfected human osteoblast cells stimulated by MTA and Biodentine.
 [Cloning and sequence analysis of variable region genes of mouse anti-human S100A9 monoclonal antibody].
 [Hepatic stellate cell conditioned medium induces proliferation and epithelial-mesenchymal transition via activating ERK1/2 signaling pathway in hepatoma cells].
 [Indirect coculture of human infrapatellar fat pad-derived stem cells with osteoarthritic chondrocytes induces their chondrogenesis].
 [Cloning, expression and activity identification of human innate immune protein apolipoprotein B mRNA editing enzyme catalytic subunit 3A (APOBEC3A)].
 Changes in Serum Creatinine Concentration and Acute Kidney Injury (AKI) Grade in Dogs Treated with Hydroxyethyl Starch 130/0.4 From 2013 to 2015.
 Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.
 Domestication and human demographic history in South America.
Enter catalog number :